FindTrial
Sign In

Incremental diagnostic value of radiomics feature of tumor habitat for improving risk stratification in thymic epithelial tumors

Incremental diagnostic value of radiomics feature of tumor habitat for improving risk stratification in thymic epithelial tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106153
Enrollment
Unknown
Registered
2025-07-18
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thymic epithelial tumors

Interventions

Gold Standard:TETs confirmed by histopathology and conforming to the WHO classification?The CECT examination should be completed within one month before the operation?Has not received any treatment re
Index test:Tumor microenvironment imaging biomarker features based on enhanced CT (CECT)

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.TETs confirmed by histopathology and conforming to the WHO classification; 2.The CECT examination should be completed within one month before the operation; 3.Has not received any treatment related to tumors;

Exclusion criteria

Exclusion criteria: 1.recurrent lesion; 2.poor-quality image (motion artifacts or incomplete coverage); 3.undetermined WHO classification;

Design outcomes

Primary

MeasureTime frame
Risk stratification of thymic epithelial tumors;—

Countries

China

Contacts

Public ContactWang Yiqiao

The Second Affiliated Hospital of Harbin Medical University

18846132078@163.com+86 18846132078

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026